MEDTRONIC INC | 38,438 Euro | +0,022 +0,06 % | |
| WKN: 858486 ISIN: US5850551061 Ticker-Symbol: MDT | Frankfurt | 17.05.13 | 18:10 Uhr |
Branche GesundheitswesenAktienmarkt S&P 100S&P 500 |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 18.05. | Medtronic's Q4 earnings: 3 things to watch | 3 | bizjournals | |
| 16.05. | Credit Suisse stuft Medtronic von Outperform auf Neutral ab | 61 | BörseGo | |
| Credit Suisse stuft Medtronic von Outperform auf Neutral ab
(© BörseGo AG 2013 - Autor: Thomas Gansneder, Redakteur) Mehr lesen zu: Credit Suisse stuft Medtronic von Outperform auf Neutral ab | ||||
| 16.05. | Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas | 5 | Seeking Alpha | |
| 14.05. | Recent 52-Week High Exceeded in Shares of Medtronic | 2 | SmarTrend | |
| 13.05. | Medtronic: The Winning Streak Continues | 10 | SmarTrend | |
| 10.05. | Medtronic : Data Show Medtronic-Exclusive LIA Software Detects Non-Medtronic Lead Issues at a Greater Rate Than Standard Impedance Monitoring | 4 | Benzinga.com | |
| 10.05. | Medtronic (MDT) Issues Encouraging Update on LIA at HRS Sessions | 1 | StreetInsider.com | |
| 10.05. | Billions In Renal Denervation: Medtronic, St Jude | 2 | Seeking Alpha | |
| 10.05. | Medtronic Looks to Continue to Trade Above its Annual-High Share Price Today | 2 | SmarTrend | |
| 08.05. | Medtronic Set to Possibly Pullback After Yesterday's Rally of 1.48% | 3 | SmarTrend | |
| 08.05. | Medtronic CEO: Blood pressure device slow to catch on in Europe | 4 | bizjournals | |
| 07.05. | Do Medtronic's Layoffs Raise a Red Flag? | 5 | Motley Fool | |
| 07.05. | Lombard Medical challenges Medtronic patent | 3 | StockMarketWire | |
| 06.05. | Medtronic gets FDA approval for heart-failure device | 1 | bizjournals | |
| 06.05. | Medtronic Says FDA Okays New Cardiac Resynchronization Therapy Devices | 59 | AFX News | |
| FRIDLEY (dpa-AFX) - Medical device maker Medtronic Inc. (MDT) on Monday
announced U.S. Food and Drug Administration approval and U.S. launch of its
newest cardiac devices: the Viva portfolio... Mehr lesen zu: Medtronic Says FDA Okays New Cardiac Resynchronization Therapy Devices | ||||
| 06.05. | Medtronic launches 2 new implanted heart devices | 1 | Yahoo-USA | |
| 06.05. | Medtronic Wins Approval for Device to Resynchronize Heart | - | Bloomberg | |
| 03.05. | Medtronic Deep Brain Stimulator Cited by FDA for Flaws | 1 | Bloomberg | |
| 02.05. | Watch for Medtronic to Potentially Pullback After Gaining 1.69% Yesterday | - | SmarTrend | |
| 02.05. | Medtronic Set to Possibly Pullback After Yesterday's Rally of 1.69% | 1 | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| FRESENIUS MEDICAL CARE | 51,80 | -2,21 % | XFRA DIVIDEND INFORMATION - 17.05.2013 - 1 |
| RHOEN-KLINIKUM | 16,625 | -0,63 % | Im Fokus: Rhön-Klinikum AG |
| FRESENIUS | 96,49 | -1,14 % | XETR DIVIDEND INFORMATION - 20.05.2013 - 1 |
| DRAEGERWERK | 98,66 | +0,54 % | Dräger-Chef räumt Nachholbedarf ein |
| CARL ZEISS MEDITEC | 24,66 | -2,47 % | Carl Zeiss Meditec: Doppelte Hochstufung |
